Targeted Retreatment of COPD Exacerbations

PHASE3CompletedINTERVENTIONAL

Enrollment

144

Participants

Timeline

Start Date

May 5, 2014

Primary Completion Date

January 22, 2019

Study Completion Date

January 22, 2019

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG

Ciprofloxacin

500 mg, twice daily for 1 week (oral)

DRUG

Placebo

One capsule, twice daily for 1 week

Trial Locations (4)

Aintree University Hospital NHS Foundation Trust, Liverpool

St Georges University Hospitals NHS Foundation Trust, London

Royal Brompton and Harefield Hospital NHS Foundation Trust, London

St Mary's Hospital, London

All Listed Sponsors

lead

Imperial College London

OTHER

NCT02300220 - Targeted Retreatment of COPD Exacerbations | Biotech Hunter | Biotech Hunter